Investment thesis
Oxford Science Enterprises is an independent investment company and venture builder based in Oxford and partnered with the University of Oxford. It funds and co-founds deep tech, life sciences and health technology companies from pre-seed through growth, working directly with researchers and entrepreneurs to turn academic science into businesses. Its portfolio spans more than 50 companies and £1.4bn in net asset value.
Past investments
| Company | Round | Date | Round size |
|---|---|---|---|
| Salience Labs Oxford, United Kingdom | Series B | Oct 2026 | €111.4M |
| Sensible Biotechnologies Oxford, United Kingdom | Series A | Oct 2026 | €41.9M |
| Stateful Robotics Oxford, United Kingdom | Pre-seed | Mar 2026 | €4.2M |
| Scripta Therapeutics Oxford, United Kingdom | Seed | Nov 2025 | €10.3M |
Sesamers coverage
October 15, 2026